Author:
Lei Ming,Wang Lei,Olatunde Oladipupo Odunayo,Singh Sudarshan,Ovatlarnporn Chitchamai,Basit Abdul,Olatunji Opeyemi Joshua
Abstract
Abstract
Background
This study investigated the in vitro antidiabetic, antioxidant, antibacterial, anti-inflammatory and antiproliferative effects of B. strigosa hydrophilic (BSTR) and lipophilic (LSB) leaves extracts. The phytochemical profile was also performed using UHPLC–ESI–QTOF–MS.
Results
The results indicated that BSTR and LSB showed excellent antioxidant properties in the DPPH scavenging, ABTS scavenging, FRAP and MCA assays. The extracts also demonstrated α-glucosidase (81.56–157.56 µg/mL) and α-amylase (204.44 µg/mL) inhibitory activities. In addition, the extracts showed significant cytotoxic and antiproliferative effects against oral squamous carcinoma (CLS-354/WT) cancer cells. Furthermore, the extracts showed excellent antibacterial activity against Listeria monocytogenes, Vibrio parahaemolyticus, Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus. Both extracts exhibited a significant reduction in nitric oxide secretion against activated macrophage cells. The UHPLC–MS analysis revealed that B. strigosa is rich in terpenoids, iridoid glycosides, flavonoids, and phenolic compounds. The plethora of these compounds may be responsible for the observed activities. In addition, the bioactive compounds identified by UHPLC–ESI–QTOF–MS were analyzed using silico molecular docking studies to determine the binding affinity with α-amylase and α-glucosidase.
Conclusions
These results suggest that B. strigosa is an excellent pharmacological active plant and it provides the basis for further studies on the exploration of its potentials in oxidative stress induced disorders.
Graphical Abstract
Publisher
Springer Science and Business Media LLC
Subject
Agronomy and Crop Science,Biochemistry,Food Science,Biotechnology
Reference52 articles.
1. Lahlou M. The success of natural products in drug discovery. Pharmacol Pharm. 2013;4:17–31.
2. Cragg GM, Newman DJ. Natural products: a continuing source of novel drug leads. Biochim Biophys Acta. 2013;1830:3670–95.
3. Uysal S, Sinan KI, Jekő J, Cziáky Z, Zengin G. Chemical characterization, comprehensive antioxidant capacity, and enzyme inhibitory potential of leaves from Pistacia terebinthus L. (Anacardiaceae). Food Biosci. 2022;48:101820.
4. Ekor M. The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol. 2014;10:4–177.
5. Olatunji OJ, Olatunde OO, Jayeoye TJ, Singh S, Nalinbenjapun S, Sripetthong S, Chunglok W, Ovatlarnporn C. New insights on Acanthus ebracteatus Vahl: UPLC-ESI-QTOF-MS profile, antioxidant, antimicrobial and anticancer activities. Molecules. 2022;27:1981.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献